269 related articles for article (PubMed ID: 23514027)
1. Orbital retinoblastoma in an adult.
Chawla B; Hada M; Kashyap S; Bakhshi S
Orbit; 2013 Apr; 32(2):146-8. PubMed ID: 23514027
[TBL] [Abstract][Full Text] [Related]
2. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Kim JW; Yau JW; Moshfeghi D; Fishman M
J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
[TBL] [Abstract][Full Text] [Related]
3. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
4. Trabeculectomy in eyes with unsuspected retinoblastoma.
Chawla B; Hada M; Seth R; Sen S; Gupta V; Kashyap S; Narasimhaiah PC
Ophthalmic Genet; 2016 Dec; 37(4):437-440. PubMed ID: 26966836
[TBL] [Abstract][Full Text] [Related]
5. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
6. What is the best treatment for retinoblastoma?
Harbour JW
Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
[No Abstract] [Full Text] [Related]
7. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
8. Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Rao R; Honavar SG; Mulay K; Reddy VAP
J AAPOS; 2018 Jun; 22(3):235-237.e2. PubMed ID: 29698780
[TBL] [Abstract][Full Text] [Related]
9. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Radhakrishnan V; Sharma S; Vishnubhatla S; Bakhshi S
Br J Ophthalmol; 2013 Jan; 97(1):52-8. PubMed ID: 23117972
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
Shah PK; Narendran V; Kalpana N
Ophthalmic Genet; 2015; 36(3):248-50. PubMed ID: 24372404
[TBL] [Abstract][Full Text] [Related]
11. Retinocytoma shows lack of response to chemoreduction.
Chung J; Turaka K; Shields CL
J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175116
[TBL] [Abstract][Full Text] [Related]
12. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
14. Management of massive orbital involvement of intraocular retinoblastoma.
Kiratli H; Bilgiç S; Ozerdem U
Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
[TBL] [Abstract][Full Text] [Related]
15. HAND-HELD OPTICAL COHERENCE TOMOGRAPHY MONITORING OF CHEMORESISTANT RETINOBLASTOMA.
Malik K; Welch RJ; Shields CL
Retin Cases Brief Rep; 2020; 14(4):368-371. PubMed ID: 29443806
[TBL] [Abstract][Full Text] [Related]
16. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
[TBL] [Abstract][Full Text] [Related]
17. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
18. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival melanoma 3 years after radiation and chemotherapy for retinoblastoma.
Mahajan A; Shields CL; Eagle RC; Mashayekhi A; Freire JE; Shields JA
J Pediatr Ophthalmol Strabismus; 2007; 44(5):300-2. PubMed ID: 17913173
[TBL] [Abstract][Full Text] [Related]
20. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
[No Abstract] [Full Text] [Related]
[Next] [New Search]